Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05781893Completed

Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy

Role: collaborator

NCT07485569Phase 1Not Yet Recruiting

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Role: collaborator

NCT07363044Not ApplicableRecruiting

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Role: collaborator

NCT06332560Not ApplicableRecruiting

Pain in Endometriosis And the Relation to Lifestyle

Role: collaborator

NCT05793554Recruiting

CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery

Role: collaborator

All 5 trials loaded